findmyKOL
Clinical trialNCT00043511CompletedPhase 1Interventional

Safety of an HIV DNA Vaccine Given to HIV Uninfected Adults

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment30HIV Infections
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Alabama Vaccine Crs

    Birmingham, Alabama, United States

  • San Francisco Vaccine and Prevention Crs

    San Francisco, California, United States

  • Ucsf, Gen. Clinical Research Ctr., Mt. Zion Hosp.

    San Francisco, California, United States

  • Fhcrc/uw Vaccine Crs

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
Primary completion
Completion
30 Apr 2003
Last update posted
14 Oct 2021
Registered enrollment
30
Registry id
NCT00043511

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.